Seguir
Jasreet Hundal
Jasreet Hundal
McDonnell Genome Institute at Washington University
Dirección de correo verificada de genome.wustl.edu
Título
Citado por
Citado por
Año
DNMT3A Mutations in Acute Myeloid Leukemia
TJ Ley, L Ding, MJ Walter, MD McLellan, T Lamprecht, DE Larson, ...
New England Journal of Medicine 363 (25), 2424-2433, 2010
21582010
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ...
Nature 515 (7528), 577-581, 2014
18322014
The origin and evolution of mutations in acute myeloid leukemia
JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ...
Cell 150 (2), 264-278, 2012
16312012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
H Matsushita, MD Vesely, DC Koboldt, CG Rickert, R Uppaluri, VJ Magrini, ...
Nature 482 (7385), 400-404, 2012
12222012
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
BM Carreno, V Magrini, M Becker-Hapak, S Kaabinejadian, J Hundal, ...
Science 348 (6236), 803-808, 2015
11182015
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ...
Nature 518 (7540), 552-555, 2015
6612015
Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
3402015
pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens
J Hundal, BM Carreno, AA Petti, GP Linette, OL Griffith, ER Mardis, ...
Genome medicine 8 (1), 1-11, 2016
2962016
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune EscapeThe Role of Tumor versus Host PD-L1 in Tumor Immune Escape
T Noguchi, JP Ward, MM Gubin, CD Arthur, SH Lee, J Hundal, MJ Selby, ...
Cancer immunology research 5 (2), 106-117, 2017
2342017
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
1772020
Genomic impact of transient low-dose decitabine treatment on primary AML cells
JM Klco, DH Spencer, TL Lamprecht, SM Sarkaria, T Wylie, V Magrini, ...
Blood, The Journal of the American Society of Hematology 121 (9), 1633-1643, 2013
1502013
U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing
T Okeyo-Owuor, BS White, R Chatrikhi, DR Mohan, S Kim, M Griffith, ...
Leukemia 29 (4), 909-917, 2015
1212015
Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation
H Celik, C Mallaney, A Kothari, EL Ostrander, E Eultgen, A Martens, ...
Blood, The Journal of the American Society of Hematology 125 (4), 619-628, 2015
982015
The prognostic effects of somatic mutations in ER-positive breast cancer
OL Griffith, NC Spies, M Anurag, M Griffith, J Luo, D Tu, B Yeo, J Kunisaki, ...
Nature communications 9 (1), 1-16, 2018
892018
pVACtools: A Computational Toolkit to Identify and Visualize Cancer NeoantigenspVACtools: Toolkit for Tumor Neoantigen Characterization
J Hundal, S Kiwala, J McMichael, CA Miller, H Xia, AT Wollam, CJ Liu, ...
Cancer immunology research 8 (3), 409-420, 2020
862020
Genome modeling system: a knowledge management platform for genomics
M Griffith, OL Griffith, SM Smith, A Ramu, MB Callaway, AM Brummett, ...
PLoS computational biology 11 (7), e1004274, 2015
782015
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor ImmunityBreast Cancer Neoantigens Can Induce Antitumor Immunity
X Zhang, S Kim, J Hundal, JM Herndon, S Li, AA Petti, SD Soysal, L Li, ...
Cancer immunology research 5 (7), 516-523, 2017
612017
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples
EK Barnell, P Ronning, KM Campbell, K Krysiak, BJ Ainscough, LM Sheta, ...
Genetics in Medicine 21 (4), 972-981, 2019
522019
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial
R Lesurf, OL Griffith, M Griffith, J Hundal, L Trani, MA Watson, R Aft, ...
Annals of Oncology 28 (5), 1070-1077, 2017
502017
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group
L De Mattos-Arruda, M Vazquez, F Finotello, R Lepore, E Porta, J Hundal, ...
Annals of oncology 31 (8), 978-990, 2020
472020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20